保留肾单位肾癌切除术的临床研究  

Keep Nephron Kidney Cancer Resection of Clinical Research

作　　者：邓健[1] 

机构地区：[1]广东省珠海市人民医院,广东珠海519000

出　　处：《中国医学创新》2015年第7期37-39,共3页Medical Innovation of China

摘　　要：目的:探究保留肾单位癌切除术的临床价值。方法:回顾性分析本院2010-2013年采用保留肾单位肾癌切除术41例及肾癌根治性切除术47例的病历资料。以肾癌根治性切除为对照组,保留肾单位肾癌切除术为实验组,对两组患者治疗情况进行分析。结果:两组患者手术均顺利完成,且两组患者平均住院时间均为11 d。临床分期均为T1N0M0。比较两组患者发现其手术时间、术中失血量及生存率比较,差异无统计学意义(P>0.05),但实验组生存质量评估较高,与对照组比较差异有统计学意义(P<0.05)。结论:保留肾单位的肾癌切除术的患者,术后生存质量明显优于根治性切除术的患者,具有较高的临床推广价值及实用意义。Objective： To explore the clinical value of nephron carcinoma resection.Method： Our hospital from 2010 to 2010 nephron kidney cancer resection 41 cases and kidney cancer radical resection of 47 cases of medical records in kidney cancer radical resection were selected for control group, with nephron kidney cancer resection as the experimental group, to analyze the effect of the two groups.Result： Two groups successfully completed, and an average length of hospital stay of the two groups were both 11 d clinical stages were T1N0M0, and intraoperative blood loss in operation time and survival rate had no significant differences （P〉0.05）, but the experimental group had a good quality assessment （P〈0.05）.Conclusion： Retain the nephron kidney cancer resection of postoperative life quality is much better than that of radical excision group of patients, has higher clinical value and practical significance.

关 键 词：保留肾单位 肾癌切除术 生存质量 

分 类 号：R737.11[医药卫生—肿瘤]